May. 24, 2022
NRx Pharmaceuticals Leaders Present Corporate Update at the H.C. Wainwright & Co. Global Investment Conference
NRx Pharmaceuticals’ interim Chief Executive Officer, Robert Besthof, and other executive leaders presented a virtual update to the company’s business via webcast at the H.C. Wainwright & Co. Global Investment Conference on Tuesday, May 24, 2022.